History
# Registration date Revision Id
2 2024-07-18, 1403/04/28 308649
1 2021-07-11, 1400/04/20 189907
Changes made to previous revision
  • Help:

    Red color represents old content. It may be empty showing addition in the new version.
    Green color represents new content. It may be empty showing deletion in the new version.

    Inline Side by side
    Added new contents, deleted old contents, contents that are not changed.
    New table contents New table contents
    Old table contents Old table contents
    Unchanged contents Unchanged contents
    Added new contents, contents that are not changed.
    Deleted old contents, contents that are not changed.
    Old table contents Old table contents
    Unchanged contents Unchanged contents
    New table contents New table contents
    Unchanged contents Unchanged contents
  • General information

    empty
    Changing the name of sampling center
    empty
    تغییر نام محل نمونه گیری
  • Recruitment centers

    #1
    Name of recruitment center - English: Simin Baspar Teyf Gostar Company
    Name of recruitment center - Persian: شرکت سیمین بسپار طیف گستر
    Full name of responsible person - English: Javad Shokri
    Full name of responsible person - Persian: جواد شکری
    Street address - English: No.48,Ferdos Street
    Street address - Persian: خیابان فردوس، پلاک 48
    City - English: Tabriz
    City - Persian: تبریز
    Province: East Azarbaijan
    Country: Iran (Islamic Republic of)
    Postal code: 5167874434
    Phone: +98 41 3384 2724
    Fax:
    Email: Shokri.j@gmail.com
    Web page address:
    Name of recruitment center - English: Dr. Shokri Laboratory
    Name of recruitment center - Persian: آزمایشگاه دکتر شکری
    Full name of responsible person - English: Javad Shokri
    Full name of responsible person - Persian: جواد شکری
    Street address - English: No.48,Ferdos Street
    Street address - Persian: خیابان فردوس، پلاک 48
    City - English: Tabriz
    City - Persian: تبریز
    Province: East Azarbaijan
    Country: Iran (Islamic Republic of)
    Postal code: 5167874434
    Phone: +98 41 3384 2724
    Fax:
    Email: Shokri.j@gmail.com
    Web page address:

Protocol summary

Study aim
Bioequivalence Study of ٰValsartan tablet 160mg manufactured by Sanamed company versus originator brand (Diovan 160mg) manufactured by Roche company
Design
Bioequivalence study, crossover, a blind, 24 healthy volunteers. Simple randomization was used for randomization
Settings and conduct
The study will be conducted in a single-blinded, cross-over and fasting, and on two series of healthy volunteers. The study will be conducted in two periods (48h). The interval between these two periods, which is called the wash-out time, is determined by the half-life of the drug plasma, which according to scientific sources at this time should be at least 5 to 7 half-life of the drug. Given that the biological half-life of the drug is in drug form, the time to clear the drug will be one week. Blood samples are taken by the doctor immediately before and after the drug is taken by the volunteers, and the steps for preparing the samples include plasma separation and drug extraction to analyze the amount of drug on them.
Participants/Inclusion and exclusion criteria
Inclusion Criteria: General Health (Liver, Heart, and Kidney), Body Mass Index (18-28), Informed consent, Age (18-45 years old) Exclusion criteria: Smoking, History of cardiovascular disease, History of liver and kidney disease, Pregnancy, Alcoholism and Narcoticism, History of allergy to ٰValsartan
Intervention groups
In this study, two groups of intervention and control are not applicable. Both groups will receive test-reference medicine and testing on two different occasions, and therefore the test results will be independent of individual differences and will only indicate differences in the formulation of the two drugs.
Main outcome variables
Maximum drug concentration, Time to reach to maximum drug concentration, Half life of drug

General information

Reason for update
Changing the name of sampling center
Acronym
IRCT registration information
IRCT registration number: IRCT20200623047902N5
Registration date: 2021-07-11, 1400/04/20
Registration timing: prospective

Last update: 2024-07-20, 1403/04/30
Update count: 1
Registration date
2021-07-11, 1400/04/20
Registrant information
Name
Elham Ghasemian
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 21 6696 5196
Email address
ghasemian@zistdaru.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2021-08-05, 1400/05/14
Expected recruitment end date
2021-10-07, 1400/07/15
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Bioequivalence study of Valsartan 160mg manufactured by Sanamed company in healthy volunteers
Public title
Bioequivalence study of Valsartan 160 mg
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
General Health (Liver, Heart and Kidney) Body Mass Index (18-28) Informed consent Age (18-60 years old)
Exclusion criteria:
Smoking History of cardiovascular disease History of liver and kidney disease Pregnancy Alcoholism and Narcoticism History of allergy to Valsartan
Age
From 18 years old to 45 years old
Gender
Both
Phase
Bioequivalence
Groups that have been masked
  • Participant
Sample size
Target sample size: 24
More than 1 sample in each individual
Number of samples in each individual: 17
blood sample
Randomization (investigator's opinion)
Randomized
Randomization description
People in the mentioned age group are invited to participate through the advertisement. People are then checked for health and healthy volunteers are identified. Each candidate is assigned a number from 1 to 24. The numbers are written on a plastic ball and poured into a container and mixed. The balls are then removed randomly from the container. The first twelve are considered as (first sequence: Valsartan 160mg manufactured by Sanamed recipient) and the second twelve are considered as (second sequence: Diovan 160mg recipient). The volunteers don't have any information about taking the test drug or brand drug
Blinding (investigator's opinion)
Single blinded
Blinding description
This study is a single-blinded clinical trial (volunteers). Valsartan (manufactured by Sanamed) and Diovan are removed from their packaging by the executor and placed in similar and coded cans. Volunteers will not be informed about receiving the brand or test dosage form
Placebo
Not used
Assignment
Crossover
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Research Ethics Committees of Tabriz University of Medical Sciences
Street address
No. 1, second floor, Hekmat Alley, Between Vesal and Palestine St., Bozorgmehr St., Valiasr St
City
Tehran
Province
Tehran
Postal code
1416844983
Approval date
2021-07-05, 1400/04/14
Ethics committee reference number
IR.TBZMED.REC.1400.308

Health conditions studied

1

Description of health condition studied
Healthy volunteers
ICD-10 code
ICD-10 code description

Primary outcomes

1

Description
Drug plasma concentration
Timepoint
Hour
Method of measurement
blood sampling

Secondary outcomes

1

Description
Pharmacokinetic parameters
Timepoint
After intervention
Method of measurement
Theoretical and pahrmacokinetic equations

Intervention groups

1

Description
Intervention group: single dose, Diovan 160 mg tablet, Novartis, as reference product
Category
Treatment - Drugs

2

Description
Intervention group: Single dose, Valsartan 160mg, Sanamed company, as test product
Category
Treatment - Drugs

Recruitment centers

1

Recruitment center
Name of recruitment center
Dr. Shokri Laboratory
Full name of responsible person
Javad Shokri
Street address
No.48,Ferdos Street
City
Tabriz
Province
East Azarbaijan
Postal code
5167874434
Phone
+98 41 3384 2724
Email
Shokri.j@gmail.com

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Sanamed pharma company
Full name of responsible person
Farshid Malek Marzban
Street address
No.1, Second floor, Hekmat alley, between Palestine and Vesal St., Bozorgmehr st., Valiasr St.
City
Tehran
Province
Tehran
Postal code
1416844983
Phone
+98 21 6640 3568
Email
info@sanamedpharma.com
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Sanamed pharma company
Proportion provided by this source
100
Public or private sector
Private
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Industry

Person responsible for general inquiries

Contact
Name of organization / entity
Islamic Azad University
Full name of responsible person
Elham Ghasemian
Position
Visitingprofessor
Latest degree
Ph.D.
Other areas of specialty/work
Medical Pharmacy
Street address
No.1, Second floor, Hekmat alley, between Palestine and Vesal St., Bozorgmehr st., Valiasr St.
City
Tehran
Province
Tehran
Postal code
1416844983
Phone
+98 21 6640 3568
Email
Ghasemian_elham@yahoo.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Islamic Azad University
Full name of responsible person
Elham Ghasemian
Position
Visitingprofessor
Latest degree
Ph.D.
Other areas of specialty/work
Medical Pharmacy
Street address
No.1, Second floor, Hekmat alley, between Palestine and Vesal St., Bozorgmehr st., Valiasr St.
City
Tehran
Province
Tehran
Postal code
1416844983
Phone
+98 21 6640 3568
Email
Ghasemian_elham@yahoo.com

Person responsible for updating data

Contact
Name of organization / entity
Islamic Azad University
Full name of responsible person
Elham Ghasemian
Position
Visiting professor
Latest degree
Ph.D.
Other areas of specialty/work
Medical Pharmacy
Street address
No.1, Second floor, Hekmat alley, between Palestine and Vesal St., Bozorgmehr st., Valiasr St.
City
Tehran
Province
Tehran
Postal code
1416844983
Phone
+98 21 6640 3568
Email
ghasemian_elham@yahoo.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
No - There is not a plan to make this available
Justification/reason for indecision/not sharing IPD
These data are as secure between researcher and related industries.
Study Protocol
No - There is not a plan to make this available
Statistical Analysis Plan
No - There is not a plan to make this available
Informed Consent Form
No - There is not a plan to make this available
Clinical Study Report
No - There is not a plan to make this available
Analytic Code
No - There is not a plan to make this available
Data Dictionary
No - There is not a plan to make this available
Loading...